Michael Fiore
Equibles does not estimate personal net worth.
About Michael Fiore
Healthequity, Inc. reported in an 8-K filed October 9, 2026 that Michael Fiore was terminated as Chief Commercial Officer, effective October 5, 2026. The proxy statement of Healthequity, Inc. reports total compensation of $4,180,404 for Michael Fiore in fiscal 2026, including a base salary of $550,000. Disclosed compensation is on record for 2 fiscal years.
“The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026.”
Affiliation history
-
Healthequity, Inc. (HQY)
Proxy statement
Start not stated–2026-10-05
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Healthequity, Inc. (HQY) | Executive Vice President and Chief Commercial Officer | $550,000 | $4,180,404 |
| 2025 | Healthequity, Inc. (HQY) | Executive Vice President and Chief Commercial Officer | $470,355 | $7,401,319 |